SCHEMBL27717136

SCHEMBL27717136

O=[N+]([O-])c1ccc(-c2c(C(F)(F)F)[nH]c3ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
ABCC8 Q09428 1/20 0.46
KCNJ11 Q14654 1/20 0.46
CTSV O60911 1/20 0.46
CTSL P07711 1/20 0.46
PSD A5PKW4 2/20 0.46
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
GYS1 P13807 1/20 0.44
MAPT P10636 1/20 0.43
PARP1 P09874 1/20 0.43
FASN P49327 1/20 0.42
TNKS O95271 1/20 0.42
GUSB P08236 1/20 0.42
NLRP3 Q96P20 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
KIF11 P52732 1/20 0.42
CDK5 Q00535 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6988913 0.78 IMPDH2 (0.56) IDO1CTSVCTSLMMP2MMP9
SCHEMBL16454839 0.78 ESR1 (0.67) IDO1MAPTFASNMEN1KMT2A
Carbazole SCHEMBL27552113 0.75 CTSV (0.67) IDO1CTSVCTSLMMP2MMP9
SCHEMBL3881804 0.74 MAP2 (0.69) IDO1CTSVCTSLMAPTPARP1
SCHEMBL27214760 0.73 ALDH1A1 (0.56) MAPTPARP1TNKSGUSBNLRP3
SCHEMBL28391349 0.71 ESR1 (0.55) CTSVCTSLMAPTFASN
SCHEMBL9666436 0.71 ALDH1A1 (0.65) MMP2MMP9MMP8MAPTFASN
Carbazole SCHEMBL28060913 0.70 ALDH1A1 (0.64) IDO1CTSVCTSLMMP2MMP9
SCHEMBL8986944 0.70 SMN1; SMN2 (0.66) IDO1CTSVCTSLMMP2MMP9
SCHEMBL28072347 0.70 PTGS2 (0.53) IDO1MAPTKMT2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101083985-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP (US) 2007-12-05 CN disclosed